phenylpropanolamine has been researched along with Syndrome in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguado-Jodar, A; Ibáñez-Nolla, J; Kvasz, M; Navarro-Artieda, R; Rejas, J; Ruiz-Torrejón, A; Sicras-Mainar, A | 1 |
| Azimi Nekoo, E; Ghanbari, Z; Haghollahi, F; Hashemi, S; Jafarabadi, M; Nemati, M | 1 |
| Chiang, CH; Chin, Hy; Lin, KC; Wang, CJ | 1 |
| Chang, YL; Ko, YJ; Lloyd, LK; Soong, YK; Tseng, LH; Wang, AC | 1 |
| Andersson, AS; Bergqvist, A; Kowalski, J; Peeker, R; Samsioe, G | 1 |
| Blot, K; Falconer, C; Marschall-Kehrel, D; Michel, MC; Radziszewski, P | 1 |
| Jonas, U; Rackley, RR | 1 |
3 trial(s) available for phenylpropanolamine and Syndrome
| Article | Year |
|---|---|
Prominent complaint: a guide to medical therapy of overactive bladder syndrome in older women.
Topics: Aged; Benzhydryl Compounds; Cresols; Double-Blind Method; Female; Humans; Iran; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Syndrome; Tolterodine Tartrate; Urinary Bladder, Overactive | 2015 |
Randomized comparison of tolterodine with vaginal estrogen cream versus tolterodine alone for the treatment of postmenopausal women with overactive bladder syndrome.
Topics: Administration, Intravaginal; Aged; Benzhydryl Compounds; Cresols; Drug Therapy, Combination; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Postmenopause; Prospective Studies; Quality of Life; Surveys and Questionnaires; Syndrome; Time Factors; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urodynamics; Vaginal Creams, Foams, and Jellies | 2009 |
Unexpected frequent hepatotoxicity of a prescription drug, flupirtine, marketed for about 30 years.
Topics: Aged; Aminopyridines; Analgesics; Benzhydryl Compounds; Chemical and Drug Induced Liver Injury; Cresols; Double-Blind Method; Female; Humans; Liver; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Syndrome; Tolterodine Tartrate; Urinary Bladder, Overactive | 2012 |
4 other study(ies) available for phenylpropanolamine and Syndrome
| Article | Year |
|---|---|
Health economics perspective of fesoterodine, tolterodine or solifenacin as first-time therapy for overactive bladder syndrome in the primary care setting in Spain.
Topics: Aged; Benzhydryl Compounds; Cholinergic Agents; Cost-Benefit Analysis; Cresols; Female; Health Care Costs; Humans; Male; Phenylpropanolamine; Prevalence; Primary Health Care; Quinuclidines; Retrospective Studies; Solifenacin Succinate; Spain; Syndrome; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents | 2013 |
Single uroflow study as a tool in predicting the possibility of abnormal voiding symptoms after the administration of antimuscarinic agents in treating overactive bladder syndrome.
Topics: Adult; Aged; Benzhydryl Compounds; Cresols; Female; Humans; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Retrospective Studies; Syndrome; Tolterodine Tartrate; Urinary Bladder, Overactive; Urination Disorders; Urodynamics; Young Adult | 2015 |
A prospective observational study of the effects of treatment with extended-release tolterodine on health-related quality of life of patients suffering overactive bladder syndrome in Sweden.
Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Quality of Life; Sweden; Syndrome; Tolterodine Tartrate; Urinary Bladder, Overactive | 2010 |
Re: Chapple CR, Martinez-Garcia R, Selvaggi L, Toozs-Hobson P, Warnack W, Drogendijk T, Wright DM, Bolodeoku J. A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome
Topics: Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Humans; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Syndrome; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Incontinence | 2006 |